Circulating microRNAs as a Fingerprint for Liver Cirrhosis

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Chen, Yan Jie ^a   Zhu, Ji Min ^a   Wu, Hao ^a   Fan, Jia ^a   Zhou, Jian ^a   Hu, Jie ^a   Yu, Qian ^a   Liu, Tao Tao ^a   Yang, Lei ^b   Wu, Chun Lei ^c   Guo, Xiao Ling ^a   Huang, Xiao Wu ^a   Shen, Xi Zhong ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 106B; MICRORNA 181B; RNA; UNCLASSIFIED DRUG; MIRN106 MICRORNA, HUMAN; MIRN181 MICRORNA, HUMAN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GENETIC ASSOCIATION; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; RNA FINGERPRINTING; RNA ISOLATION; VALIDATION PROCESS; AGED; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; GENETICS; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MICRORNAS; MIDDLE AGED;

EID: 84879275954     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066577     Document Type: Article

References (34)

1. Schuppan D, Afdhal NH, (2008) Liver cirrhosis. Lancet 371: 838-851.
2. Fleming KM, Aithal GP, Solaymani-Dodaran M, Card TR, West J, (2008) Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: a general population-based study. J Hepatol 49: 732-738.
3. Povero D, Busletta C, Novo E, di Bonzo LV, Cannito S, et al. (2010) Liver fibrosis: a dynamic and potentially reversible process. Histol Histopathol 25: 1075-1091.
4. Pinzani M, Vizzutti F (2008) Fibrosis and cirrhosis reversibility: clinical features and implications. Clin Liver Dis 12: 901-913, x.
5. Gieling RG, Burt AD, Mann DA (2008) Fibrosis and cirrhosis reversibility- molecular mechanisms. Clin Liver Dis 12: 915-937, xi.
6. Bedossa P, Dargere D, Paradis V, (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 38: 1449-1457.
7. Schmeltzer PA, Talwalkar JA, (2011) Noninvasive tools to assess hepatic fibrosis: ready for prime time? Gastroenterol Clin North Am 40: 507-521.
8. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
9. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
10. He L, Hannon GJ, (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531.
11. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
12. Ichikawa D, Komatsu S, Konishi H, Otsuji E (2012) Circulating microRNA in digestive tract cancers. Gastroenterology 142: 1074-1078 e1071.
13. Zhou J, Yu L, Gao X, Hu J, Wang J, et al. (2011) Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 29: 4781-4788.
14. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
15. Scheuer PJ, (1991) Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13: 372-374.
16. Scheuer PJ, (1995) The nomenclature of chronic hepatitis: time for a change. J Hepatol 22: 112-114.
17. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, et al. (2010) Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 31: 2765-2773.
18. Devaux Y, Vausort M, Goretti E, Nazarov PV, Azuaje F, et al. (2012) Use of circulating microRNAs to diagnose acute myocardial infarction. Clin Chem 58: 559-567.
19. Zhao Z, Zhao Q, Warrick J, Lockwood CM, Woodworth A, et al. (2012) Circulating microRNA miR-323-3p as a biomarker of ectopic pregnancy. Clin Chem 58: 896-905.
20. Alevizos I, Illei GG, (2010) MicroRNAs as biomarkers in rheumatic diseases. Nature Reviews Rheumatology 6: 391-398.
21. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, et al. (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer cell 13: 48-57.
22. Baker SG, (2009) Improving the biomarker pipeline to develop and evaluate cancer screening tests. J Natl Cancer Inst 101: 1116-1119.
23. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, et al. (2011) Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53: 209-218.
24. Roderburg C, Mollnow T, Bongaerts B, Elfimova N, Vargas Cardenas D, et al. (2012) Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis. PLoS One 7: e32999.
25. Waidmann O, Koberle V, Brunner F, Zeuzem S, Piiper A, et al. (2012) Serum MicroRNA-122 Predicts Survival in Patients with Liver Cirrhosis. PLoS One 7: e45652.
26. Wang B, Li W, Guo K, Xiao Y, Wang Y, et al. (2012) miR-181b Promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients. Biochem Biophys Res Commun 421: 4-8.
27. Wynn TA, (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210.
28. Wang H, Liu J, Zong Y, Xu Y, Deng W, et al. (2010) miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-beta type II receptor. Brain Res 1357: 166-174.
29. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, et al. (2008) MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 28: 2167-2174.
30. van Almen GC, Verhesen W, van Leeuwen RE, van de Vrie M, Eurlings C, et al. (2011) MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell 10: 769-779.
31. Wu H, Wang F, Hu S, Yin C, Li X, et al. (2012) MiR-20a and miR-106b negatively regulate autophagy induced by leucine deprivation via suppression of ULK1 expression in C2C12 myoblasts. Cell Signal 24: 2179-2186.
32. Leask A, Abraham DJ, (2006) All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119: 4803-4810.
33. Petrocca F, Vecchione A, Croce CM, (2008) Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 68: 8191-8194.
34. Kodama T, Takehara T, Hikita H, Shimizu S, Shigekawa M, et al. (2011) Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice. J Clin Invest 121: 3343-3356.